Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: Bhag Karamchandani who wrote (5224)	8/31/1998 10:46:00 AM
From: George T. Santamaria	Respond to of 6136

<AG3340. I generally share your sentiment but could you expand on "we need to have the milestones clearly restated and identified" (specially the restated part). Thanks.> It's been so long since we have heard anything that most investors have forgotten what the projected date of Ph III approval is. I think that it is late next year or in '00. One time I called IR and the assistants could not even tell me clearly whether the product is in Ph II or Ph III or what it means to be in Ph II/III trials. This is not something that should not be left for a secretary to explain. The waters have been muddied -- I should have pulled my bets out then. I don't consider myself to be a dummy but imagine what happens if some totally unknowledgeable investor calls in -- it becomes an unqualified sell signal.